StonvexLoading…
StonvexStonvexStonvexCore line items from ENTG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $811.90M | $3.20B | $2.37B | $1.57B |
Operating Income | $141.60M | $455.90M | $351.00M | $228.40M |
Net Income | $92.00M | $235.60M | $186.20M | $52.80M |
EPS (Diluted) | $0.60 | $1.55 | $1.22 | $0.76 |
Total Assets | $8.48B | $8.35B | $8.40B | $8.45B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $442.70M | $360.40M | $399.80M | $376.80M |
Free Cash Flow OCF − CapEx | $141.50M | $396.20M | $262.20M | $79.40M |
Shares Outstanding | 152.30M | 151.90M | 151.60M | 152.00M |